Casi Pharmaceuticals

Last update: October 18, 2019

United States (USA) Its 15 main executives
Its subsidiary

Recent executive movements at Casi Pharmaceuticals

Larry Zhang, who was President of Beijing, is promoted to President  (news posted on September 19 2019).
Wei-Wu He, who was Executive Chairman of the Board, is promoted to Chief Executive Officer and Chairman of the Board  (news posted on April 2 2019).

Create an alert
to follow the executive moves at Casi Pharmaceuticals.

Latest M&A news in Pharmaceuticals.

Novartis has announced the acquisition of Medicines (posted on Nov 27, 2019).
Glaukos has acquired Avedro (posted on Nov 22, 2019).
Bristol-Myers Squibb has acquired Celgene (posted on Nov 21, 2019).

Casi Pharmaceuticals is one of the...

Latest news about Casi Pharmaceuticals

Casi Pharmaceuticals on Wikipedia, Google News & Yahoo Finance

Casi Pharmaceuticals on LinkedIn, Twitter & YouTube

Casi Pharmaceuticals has 1,959 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Pfizer (United States (USA)).

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.